The news that Germany backtracked on all its plans for a regulated cannabis market in light of not getting EU approval, was a bit of a blow. However, another EU country has its own plans. The Czech Republic is talking about a regulated market, and might now be the first country in the EU to make it happen.
Czech Republic announced plans for regulated weed market in 2022
Last fall, following in the footsteps of Germany and Switzerland, the Czech Republic made its own announcement about legalizing recreational cannabis and opening a regulated market. At the time it seemed the Czech government wanted to make its plans in tandem with its next-door-neighbor Germany.
Last fall, the reports were minimal, with no specific information given about anything. It wasn’t even clear which government agency the announcement came through. The only information given, was the sheer idea to do it. However, it was said that the coalition government was in the midst of drafting legislation, with an expected release date of March 2023. The hope at the time, was to have the market up and running by early 2024.
One of the few pieces of information let out, was that bill draft-writing was under the direction of drug commissioner Jindřich Vobořil, and that according to Vobořil, the idea was to do this in conjunction with Germany. At the time he stated, “We are in contact with our German colleagues, and we have repeatedly confirmed that we want to coordinate by consulting each other on our proposals.”
Thank you for coming by. We offer theCannadelics Weekly Newsletter for ongoing updates; which also comes chock full of sweet promos on cannabis buds, vapes & paraphernalia, edibles, cannabinoids (including HHC), amanita mushroom products, and a ton more. We support feeling good, and want to help you get there!
However, in terms of doing this with Germany, earlier in April it was reported that Germany would not follow through with its stated idea for a market anytime soon. The EU didn’t approve of the country’s plan. So, what does that now mean for the Czech Republic, and its own ambitions for a regulated market? Perhaps Germany’s move actually brings them closer together.
Czech Republic introduces its plans for a regulated market, sort of…
On April 6th, 2023, it was reported that the Czech Republic announced its own plans for a regulated weed market in the wake of Germany’s failure to have its plans approved by the EU. The Czech cabinet passed a drug strategy plan; although the exact rules of the plan are still to be set. According to Prime Minister Petr Fiala, an ‘expert group’ will be in charge of doing this.
The thing is, this announcement does little more to shed light on what’s going on, than the original announcement last fall. Something was passed, but no details are shared, except for a few vague ones. Like that this new drug strategy is set to run until the end of 2025, and includes as part of it, a regulated recreational cannabis market.
Fiala, in all his vagueness, said this new plan provides a balanced approach, and takes into consideration the needs of a drug policy, along with an eye on the international landscape. He stated that the plan takes into consideration children, and mitigating risks in terms of their access to drugs.
The new plan is not just about cannabis, but is an Addiction Policy Action Plan, that sets regulation for the prevention, use, sale and advertising of many different addictive substances; including alcohol, cigarettes and cannabis; as well as gambling. According to Vobořil, there are five priorities attached to this plan: 1) cannabis policy, 2) taxation, 3) prevention, 4) treatment, and 5) dealing with the EU and any possible repercussions.
Why number 2 and 5 are interesting
The second and fifth points are interesting. In the second, the plan touches on something that every country with legalization policies tends to get excited for: taxes! According to Vobořil, there will be new taxes for addictive substances, with the thought this could generate up to CZK 15 billion ($702.2 million) yearly for the country. The cannabis market is estimated to bring in an additional four billion extra on its own.
Cannabis taxes
One must wonder when looking at such statements, if the government is actually paying attention to what’s currently happening with legal markets now. Depending on how inflated that number is, the country might be very let down by this prediction in the end; especially considering its high rate of usage now, which is entirely dependent on a thriving black market.
The last point is also interesting, and likely a reason for the lack of hard information provided. Unless we find out this is really just a club setup, we know the Czech Republic will have to deal with the EU in the same way Germany did. Perhaps the quietness is simply so as not to make statements it might have to go back on. We don’t know yet if the Czech Republic plans to bend to EU laws, or go off on its own.
The plan only passed the cabinet thus far. Another probable reason we aren’t told much, is likely because the plan must clear both sides of the county’s parliament, and obtain a sign-off from the president, which might lead to major changes in the process. Essentially, these are early stages, and given the issues that Germany had in making big announcements, and not living up to them; perhaps it bodes well for the Czech Republic to keep the details on the down low for now.
While some publications are proclaiming in headlines that the revised policy allows for things like buying up to five grams a day; that information was not released. As tends to be the case with headlines meant to grab attention, these articles are just speculating based on past statements.
What’s the current state of cannabis in Czech Republic
Considering it doesn’t have recreational cannabis, the Czech Republic is still one of the more easygoing countries in terms of cannabis regulation. The country passed a decriminalization policy in 2010, which allows the possession of up to 10 grams, and the cultivation of up to five plants. If a person has more than these amounts, but just for personal use, they can incur a civil fine up to CZK 15,000, but usually not this much. Jail time of up to one year is also possible for some offenses.
The above information is for minor infractions. For things like sales or trafficking, a person can be imprisoned for 2-10 years, though the minimum of two years is actually a requirement. The maximum sentence goes up to 18 years for the most extreme crimes, and cannot go above that limit. If traffickers aren’t making a significant income, they might get out of heavier punishments with a suspended sentence, or something in that realm.
Cannabis usage in Czech Republic
Since 2013, the Czech Republic has allowed medical cannabis, with sales through pharmacies if the person has a doctor’s prescription. Medical patients are legally entitled to up to 180 grams of dry flower per month. This program pushed the Czech Republic into growing its own weed, as in the beginning the industry ran off of imports only.
The Czech Republic has something in common with Switzerland which sets it apart from the rest of the EU: it allows 1% THC in industrial cannabis products, rather than the .2% (now .3%) allowable by the EU. Perhaps this little difference says a lot about the country and what we can expect. If the Czech Republic was willing to go up against the EU for this, it might also be willing to go up against the EU in terms of opening a recreational market.
However, it should be remembered that back when announcements were first made last year, that Vobořil indicated a different less divisive direction via Facebook post. In terms of working with Germany he said, “My colleagues in Germany are talking about permitted quantities, and they don’t have the cannabis clubs that we foresee. I certainly want to hold the cannabis clubs until my last breath. This model seems very useful to me, at least for the first few years.” This might be the best indication for what we should expect moving forward.
Conclusion
When it really comes to news, this story is hardly worth covering, because practically no new news is offered. What we can see is that the Czech Republic is charging ahead with its own plans for a recreational market, whatever they are. And though it sounds like the country is aware of needing to deal with the EU, its also quite likely that the plans its working to establish, might not attempt to break with EU mandate. Stay tuned to life to find out.
Welcome to the site! We’re happy you’re joining us at Cannadelics.com; an independent new source that works daily to report on the burgeoning cannabis and hallucinogen industries. Join us frequently to stay aware of everything going on; and sign up to our Cannadelics Weekly Newsletter, to ensure you’re never late to get the news.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
Photo by yavdat/Getty Images
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.
Not everyone has access to marijuana to help them sleep – good news, hemp is available.
it’s estimated 50 to 70 million Canadian and American adults experience sleep disorders or disturbances, and about one-third of adults don’t regularly get the recommended amount. Hemp has emerged as a promising natural remedy for those seeking better sleep. With its calming properties and potential to address various sleep-related issues, hemp-derived products are gaining popularity among individuals looking to improve their rest. Here is how hemp helps you sleep.
Hemp contains several compounds contributing to better sleep quality. Cannabidiol (CBD), a non-psychoactive component of hemp, has shown potential in promoting relaxation and reducing anxiety, which can often interfere with a good night’s rest. Studies suggest that CBD may help individuals fall asleep faster and experience fewer sleep disturbances throughout the night.
When formulated and used properly, preliminary research and user reports suggest that hemp gummies improve subjective sleep quality. Users of quality hemp sleep gummies report feeling more rested, a better quality of sleep and fewer awakenings in the night. However, clinical research has shown that over consumption of THC negatively impacts the quality of sleep, especially with long term use.
Wana Brands has launched a hemp sleeping product nationally, Mike Hennesy, Vice President of Innovation shared the following about how it works. Naturally hemp-derived sleep gummies contain the same cannabinoids like CBD, CBN, and THC as cannabis or marijuana. These ingredients interact with receptors in the body’s endocannabinoid system, which plays a role in regulating mood, stress, and sleep-wake cycles. For example, CBD may promote relaxation and reduce anxiety, CBN can relieve discomfort and reduce awakenings, while THC can shorten the time it takes to fall asleep, especially at low doses. Together, they may help ease the mind and body into a sleep-ready state.
The best sleep products don’t rely on just one cannabinoid like CBN but instead use a combination of cannabinoids, terpenes, and other sleep-supporting ingredients such as melatonin. This is because the reasons for sleeplessness are multifaceted, and include trouble falling asleep, staying asleep, chronic, pain and anxiety. Each ingredient targets different root causes as well as synergizes with the other cannabinoids and terpenes for the best night sleep.
Longer lasting formulations can actually help reduce awakenings in the night. CBN has been shown in recent research to reduce the number of times you wake up in the night. Combined with other cannabinoids they can synergize to reduce discomfort and anxiety helping consumers stay asleep.
If you do wake up in the middle of the night and can’t fall back asleep products including CBD and CBG to reduce middle of the night anxiety and racing thoughts that can keep us awake, and they have only 1mg of THC so you wake up refreshed and not high in the morning.
For most people, hemp-derived cannabinoids are considered safe and non-intoxicating, with a low risk of dependence. When THC is included in small amounts, it can produce mild effects and can help us fall asleep faster. It generally poses a minimal risk when used in moderation, but there is a potential for dependence if overused, just like with any sleep aid. Adverse events are far more prevalent in pharmaceutical and even over the counter sleep aids than with hemp-derived cannabinoids.
The key is responsible use, including starting with a low dose and taking breaks when needed. If you rely on it every night at high doses, your body may adjust, and it can be habitual. But when used in moderation and with a well-balanced formula, cannabis can be a sustainable part of a healthy sleep routine.
Alcohol has some negative side effects, but cannabis could have one positive health benefit – it might help your good cholesterol.
In the late 1980s cholesterol test became come as the impact of it on the body and heart was becoming more evident. Research shows good cholesterol (HDL) helps remove excess cholesterol from the body, while “bad” cholesterol (LDL) can build up in arteries, potentially leading to heart disease. Alcohol and tobacco are known to be rough on the body, but can marijuana help cholesterol?
Marijuana’s potential impact on cholesterol is an emerging area of research, offering both promising insights and areas for further exploration. While studies have yet to reach definitive conclusions, evidence suggests that cannabis may influence cholesterol levels in ways that could benefit cardiovascular health under certain conditions.
Cannabis contains cannabinoids like THC and CBD, which interact with the body’s endocannabinoid system. This system plays a role in regulating various physiological processes, including lipid metabolism. Some studies have indicated that marijuana use might improve cholesterol profiles by increasing high-density lipoprotein (HDL), commonly known as “good cholesterol.” For instance, research published in BMJ Open found that marijuana users had elevated levels of HDL cholesterol, which is associated with better cardiovascular health.
Moreover, cannabis has demonstrated anti-inflammatory properties and the ability to regulate blood glucose levels. These effects can indirectly support heart health by reducing risk factors associated with high cholesterol, such as diabetes and obesity. Additionally, cannabinoids like CBD may help protect the heart from oxidative stress and inflammation, further enhancing cardiovascular health.
Cannabis has also been linked to weight management benefits, which can positively impact cholesterol levels. Studies have shown that marijuana use may reduce abdominal fat and improve metabolic parameters. Since obesity is a major contributor to high LDL cholesterol levels, these findings suggest that cannabis could play a supportive role in maintaining healthy cholesterol levels.
While some studies highlight potential benefits of cannabis for cholesterol and heart health, others caution against its risks. Daily marijuana use has been associated with an increased risk of heart failure and other cardiovascular issues. However, research also indicates that cannabis may reduce the risk of atrial fibrillation and improve outcomes following heart attacks.